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Abstract
Background: Pax7 is a transcription factor involved in the specification and maintenance of muscle stem cells
(MuSCs). Upon injury, MuSCs leave their quiescent state, downregulate Pax7 and differentiate, contributing to
skeletal muscle regeneration. In the majority of regeneration studies, MuSCs are isolated by fluorescence-activated
sorting (FACS), based on cell surface markers. It is known that MuSCs are a heterogeneous population and only a small
percentage of isolated cells are true stem cells that are able to self-renew. A strong Pax7 reporter line would
be valuable to study the in vivo behavior of Pax7-expressing stem cells.
Methods: We generated and characterized the muscle properties of a new transgenic Pax7EGFP mouse. Utilizing
traditional immunofluorescence assays, we analyzed whole embryos and muscle sections by fluorescence microscopy,
in addition to whole skeletal muscles by 2-photon microscopy, to detect the specificity of EGFP expression. Skeletal
muscles from Pax7EGFP mice were also evaluated in steady state and under injury conditions. Finally, MuSCs-derived
from Pax7EGFP and control mice were sorted and analyzed by FACS and their myogenic activity was comparatively
examined.
Results: Our studies provide a new Pax7 reporter line with robust EGFP expression, detectable by both flow cytometry
and fluorescence microscopy. Pax7EGFP-derived MuSCs have identical properties to that of wild-type MuSCs, both
in vitro and in vivo, excluding any positional effect due to the transgene insertion. Furthermore, we demonstrated high
specificity of EGFP to label MuSCs in a temporal manner that recapitulates the reported Pax7 expression pattern.
Interestingly, immunofluorescence analysis showed that the robust expression of EGFP marks cells in the satellite
cell position of adult muscles in fixed and live tissues.
Conclusions: This mouse could be an invaluable tool for the study of a variety of questions related to MuSC
biology, including but not limited to population heterogeneity, polarity, aging, regeneration, and motility, either
by itself or in combination with mice harboring additional genetic alterations.
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Background
The Pax7 transcription factor is a component of the
paired box family, which is involved in the specification
and maintenance of stem and progenitor cells [1] across
multiple species [2–7], including humans [8]. During
early murine embryonic development, beginning around
e8.5, Pax7 is expressed in neural crest cells, the neural
tube, the frontonasal region, and the somites [9, 10],
which ultimately form skeletal muscle [11]. As develop-
ment progresses, the activity of Pax7 contributes to
bones of the skull, the brain, olfactory epithelium, nasal
septum cartilage, as well as skeletal muscle, in conjunc-
tion with Pax3 [9, 10, 12].
From the original characterization of Pax7 [2] as a
marker of satellite cells (also called muscle stem cells or
MuSCs), there has been a continuous effort among sci-
entists to understand its function. Ablation of Pax7 at
conception resulted in a substantial loss of satellite cells
in pups, which displayed muscle defects [2, 13, 14]. In
non-injured adult muscle, MuSCs remain quiescent, are
transcriptionally inactive and express high levels of Pax7
protein [15]. As result of an injury, they become acti-
vated; proliferate and differentiate into myogenic pro-
genitors. The activity of the Pax7 transcription factor
contributes to MuSC self-renewal, and Pax7+ cells can
contribute to myogenesis following injury in the adult
[15], as evidenced by transplantation models of freshly
isolated cells [16].
During the muscle regeneration process, particularly at
the proliferation stage of MuSCs, the expression of Pax7 is
carefully controlled [17, 18]. Specifically, MuSCs that
maintain a high expression of Pax7 protein retain template
DNA strands, exhibit lower metabolic activity, and express
stem cell markers, while MuSCs exhibiting low Pax7 ex-
pression undergo random DNA segregation and are myo-
genically committed during the regeneration process [19].
MuSCs studies remain dependent on prospective cell iso-
lation methods using fluorescence-activated cell sorting
(FACS). Since most of the cell surface markers used in
flow cytometry are also expressed on other cell types,
these markers can only be utilized in combinations and
together with lineage negative selections [16, 20–23].
Recent evidence demonstrates that MuSC population is
heterogeneous [20, 24–30]. They differ in their gene ex-
pression signatures, differentiation, lineage potential, and
stemness, since only a small percentage of isolated cells
are true stem cells able to self-renew (discussed in [18]).
Using single fiber isolation methods, muscle stem cells
have been shown to self-renew through asymmetric div-
ision to refill the stem cell reservoir and to produce more
committed progenitors, which are associated with muscle
growth and regeneration [31]. Implementing Cre-Lox
P-based lineage-tracking methods to analyze the func-
tional role of Pax7 in adult muscle stem cells resulted in
different outcomes [32–34], presumably due to limitations
in Cre-Lox technology and the contribution of stem cells
that escaped gene recombination (discussed in [35]).
Deciphering the function(s) of Pax7 in an in vivo con-
text has proven difficult. In this study, we describe and
analyze the properties of a new transgenic reporter
mouse model, Pax7EGFP, which marks the muscle stem
cells, which are both Pax7 and CD34/α7-integrin
dual-positive. Importantly, we have found that the EGFP
protein in our mouse is a dynamic marker of Pax7,
which gradually declines upon MuSC activation. We fur-
ther show that the EGFP intensity of Pax7EGFP MuSCs
is very bright and can be visualized by fluorescence mi-
croscopy both in vitro (native and antibody stained) but
more importantly in vivo (by two-photon microscopy),
making this mouse model an excellent tool to study the
dynamic behaviors of MuSCs in live animals during
homeostasis and/or disease conditions.
Methods
Pax7EGFP mouse generation
The EGFP coding sequence was inserted in-frame imme-
diately downstream of the first exon of Pax7, within the
RP23-204F20 bacterial artificial chromosome (BAC; start
position: 82608). This 213 Kb BAC contains DNA se-
quence 81 Kb upstream to 34 Kb downstream of the
Pax7 locus. Thus, the Pax7 endogenous promoter and
regulatory elements drive expression of the EGFP. The
resulting construct, named Pax7-EGFP hereafter, was
linearized and microinjected into the pronuclei of fertil-
ized eggs, which were then implanted into pseudopreg-
nant female mice. Progeny were analyzed for genomic
integration of the transgene by PCR. Transgene-positive
progeny (founders) were crossed with wild-type C57Bl6
mice (Stock #000664 from Jackson Laboratories) to fa-
cilitate the expansion of the lines. MuSCs were isolated
from mice deriving from these lines and were further
screened for the expression level of EGFP protein by
flow cytometry. The line with the most robust expres-
sion of EGFP in MuSCs (Additional file 1: Figure S1)
was amplified further to establish the Pax7EGFP line.
Experimental mice
The Pax7EGFP heterozygous mice were compared to
wild-type mice or control Pax7EGFP negative litter-
mates. For some experiments (Additional files 2 and
3: Figures S2 and S3), RosamTmG/Pax7Cre heterozy-
gous mice (breeding of Jackson Labs stocks: #007676
and #010530 homozygotes) were also used for com-
parisons. All mice were housed and bred in accord-
ance with the IACUC guidelines of the University of
Pennsylvania.
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Genotyping
To identify which mice carry the Pax7EGFP BAC, gen-
omic DNA was isolated from ear snips with genomic
DNA isolation buffer (100 mM Tris, pH 8.0, 5 mM EDTA,
200 mM NaCl, 0.2% SDS, 0.2 mg/mL proteinase K)
Primers utilized were P7EGFP-pr1: 5′-TGAAAGGAA
GAGACGCCAAG-3′, and P7EGFP-pr2: 5′- TCGTTGG
GGTCTTTGCTCAG-3′. PCR products were generated
with GoTaq Green (Promega) under the following condi-
tions a 94 °C hold for 2′, 36 cycles of 94 °C for 30″, 56 °C
for 30″, 72 °C for 1′ followed by a 72 °C hold for 10′.
Mice that are positive for Pax7EGFP (both homozygous
and heterozygous) will yield a 706-basepair product.
Embryo isolation and imaging
To isolate embryos, Pax7EGFP heterozygous male mice
were bred with wild-type C57Bl/6 females (stock
#000664 from Jackson Labs). Following confirmation of
plugs, males were removed from the cage. Pregnant
mothers were sacrificed 11.5 or 14.5 days after timed
mating set-up. Embryos were dissected from the uterine
horns and imaged using an Olympus SZX2 stereomicro-
scope equipped with fluorescence. Fluorescent and
bright field images were merged using Fiji.
Muscle stem cell (MuSC) isolation
Hindlimb muscles (quadriceps, gastrocnemius, and tibialis
anterior) were dissected and MuSCs collected as described
[36]. Briefly, tissue was enzymatically dissociated with 0.1%
collagenase (Sigma) and 4.8 units/mL dispase (Roche) in
DMEM, using the gentleMACs system (Miltenyi Biotech).
The cell slurry was pulled through a 21-gauge needle until
all remaining muscle tissue was broken apart, after which
the cell solution was filtered through a 40 μm cell strainer.
Red blood cells were eliminated with red cell lysis buffer
(eBioscience). Cells were stained with biotinylated
antibodies (CD31 from eBioscience; Sca1, CD45, and
CD11b from BD Biosciences) followed by staining with
streptavidin-conjugated PE-Cy7 (BioLegend), Alexa Fluor
647-conjugated α7-integrin antibody (AbLab), and Brilliant
Violet 421-conjugated CD34 antibody (BD Biosciences).
The viability dye 7-AAD (Sigma) was added and cells were
either sorted on a FACS Aria II cell sorter (BD Biosciences)
or analyzed on an LSRII (BD Biosciences).
MuSC in vitro expansion and differentiation
MuSCs were FACS-sorted and plated on laminin-coated
8-well chamber slides (Nunc LabTek II; for proliferation)
or 96-well collagen-coated plates (for differentiation) in
myoblast media [DMEM/F12 supplemented with 15%
FBS, 1× Glutamax, 1× antibiotic-antimycotic, and 1/
10,000 dilution of 25 μg/mL bFGF (Promega)]. After cul-
turing for 2 days, cells were either fixed in 4%PFA/PBS
(for Pax7 and MyoD staining) or were washed and fresh
myoblast media was media added. After three more days
of culture, cells were transferred to differentiation
medium (DMEM, 5% horse serum, 1× Glutamax, 1×
antibiotic-antimycotic) for 2 days before fixation with 4%
PFA/PBS. Cells were permeabilized in 0.5% Triton
X-100/PBS and stained with antibodies against Pax7
(mouse monoclonal; DSHB supernatant; 1/10), MyoD
(either mouse monoclonal, DAKO clone 5.8A, 1/50 or
rabbit polyclonal, C-20, Santa Cruz 1/50), GFP-tag
(ThermoFisher, 1/200), myosin heavy chain (Santa Cruz,
clone H300, rabbit polyclonal, 1/50 dilution), and myo-
genin (DSHB supernatant, clone F5D, 1/10). Secondary
antibodies used were Alex Fluor 555 goat anti-mouse IgG,
and Alexa Fluor 647 or Alexa Fluor 488 goat anti-rabbit
IgG, all at 1/500 dilution. Coverslips were mounted with
Fluromount G with DAPI (SouthernBiotech). Pax7,
MyoD, and GFP stained cells were imaged on a Nikon
eclipse Ni-U equipped with a Nikon Qi1Mc 14-bit cam-
era, while embryonic myosin heavy chain and myogenin
were imaged on a Zeiss confocal 710 microscope.
MuSC live cell imaging
Twenty thousand FACS-sorted GFP+ MuSCs from Pax7-
EGFP heterozygous mice were plated on collagen-coated
16-well chamber slides (Nunc LabTek II) in live-cell im-
aging medium (DMEM/F12 without phenol red, 15%
FBS, 1× Glutamax, 1× antibiotic-antimycotic, 25 μg/mL
bFGF). MuSCs were imaged for the presence of GFP 0,
12, 24, 48, 72, and 96 h after plating with a Nikon
Eclipse TE2000-U inverted microscope equipped with a
Plan Fluor ELWD 20× Ph1 ADL objective and a
Pco.edge sCMOS 16-bit camera. All imaging for GFP
was taken at the same exposure/intensity settings, where
multiple random fields (N = 3) were imaged per well at
each time point. n = 3 mice, where the MuSCs from each
mouse were plated in their own well.
Muscle fiber histology and analysis
Non-injured gastrocnemius, quadriceps, and tibialis an-
terior muscles were isolated from Pax7EGFP heterozy-
gous mice or control (Pax7EGFP negative) mice of the
same gender. Muscles were fixed in 2% PFA/PBS for 2 h
at 4 °C and placed in 20% sucrose overnight at 4 °C. The
following day, muscles were embedded in OCT medium
(NEG-50; Richard Allen Scientific) and froze in liquid
N2-chilled 2-methylbutane. 10 μm cryosections were
placed on Superfrost plus slides, and sections were
stained with hematoxylin and eosin. Images of tissue
sections were taken on a Nikon Eclipse Ni-U widefield
epifluorescence microscope equipped with a Nikon
DS-F12 camera. For the fiber analyses, images were enu-
merated and quantitated using ImageJ.
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Pax7 immunofluorescence of tissue sections
Non-injured tibialis anterior muscles were dissected,
processed, and cryosectioned, as described above. Sec-
tions were permeabilized in 0.5% Triton X-100/PBS,
washed with PBS, and underwent heat-mediated antigen
retrieval with EDTA buffer (1 mM EDTA, pH 8.0, 0.05%
Tween-20). Following avidin/biotin blocking (Vector
Labs), mouse IgGs were blocked with mouse on mouse
IgG blocking reagent (Vector Labs). Sections were then
further blocked with 3%BSA/0.1% Triton X-100/PBS be-
fore addition of primary antibodies [Pax7 (PAX7) mouse
monoclonal; Santa Cruz; 1/20; GFP-tag rabbit poly-
clonal; ThermoFisher; 1/250] in 3%BSA/0.1% Triton
X-100/PBS overnight at 4 °C. The following day, sec-
tions were washed and stained with Alexa Fluor 488
goat anti-Rabbit IgG (1/250; for EGFP), Alexa Fluor
555-conjugated wheat germ agglutinin (WGA; Ther-
moFisher; 1 μg/mL; to stain the extracellular matrix),
and Alexa Fluor 647-conjugated streptavidin (BioLe-
gend; 1/250; to mark Pax7+ cells) in 3% BSA/0.1%
Triton X-100/PBS at room temperature. After wash-
ing with PBS, sections were stained with 20 μg/mL
DAPI and coverslips were mounted with Prolong dia-
mond antifade reagent (ThermoFisher). For imaging
for the presence of GFP in tissue sections without
antibody staining, muscle was processed as above up
until after sectioning and stained with 20 μg/mL
DAPI. Coverslips were mounted with Prolong dia-
mond antifade reagent (ThermoFisher).
Whole muscle imaging
The tibialis anterior muscle was mounted on a
custom made platform, and a coverslip was lowered
from the top to make contact with the exposed
muscle. High-resolution serial optical sections were
acquired with an Olympus FV1200MPE microscope
equipped with a Chameleon Vision II 2-photon
laser. A laser beam that was tuned at 890 nm was
focused through a × 10 objective lens (Olympus
UPLSAPO, N.A. 0.4) and scanned with a field of
view of 1270 μm2. The emission light was then
spectrally separated into green (495–540 nm) and
red (575-630 nm) channels and collected by two
GaAsP photo-detectors. The following acquisition
settings were used for the green and red
photo-detectors, respectively: HV: 550/525 V; Gain
1/1, Offset: 3/4%. Serial optical sections were ac-
quired in 4 μm steps for total range of 200 μm from
the surface of the muscle. Muscle fibers were
marked by the appearance of Second Harmonic
Generation (SHG) in red channel [37]. Muscle stem
cells marked with EGFP were clearly visible in the
green channel.
Statistical analysis
Significance was determined using two-tailed unpaired t
tests with Welch’s correction using GraphPad Prism 6 soft-
ware. *p < 0.05; **p < 0.01; ***p < 0.001; NS = not significant.
Other procedures not listed here can be found in the
Supplementary methods section (Additional file 4).
Results
Generation of a Pax7EGFP mouse and transgene
expression
The Pax7EGFP mouse was generated by cloning of the
EGFP gene into the first exon of the Pax7 gene into a
BAC genomic clone (RP23-204F20, obtained from
ImaGenes; Additional file 1: Figure S1a), using ET re-
combination [38]. The resulting construct (Pax7-EGFP)
uses the endogenous Pax7 promoter driving expression
of EGFP and utilizes its endogenous putative proximal
and distal enhancer elements. The Pax7-EGFP targeting
vector was microinjected into fertilized eggs of C57Bl/6
female mice. More than 150 offspring were genotyped
for EGFP integration, which ultimately yielded five pos-
sible transgenic mouse lines based on the presence of
the GFP transgene (Additional file 1: Figure S1b). Since
Pax7 expression is robust in quiescent MuSCs [17], we
next sought to determine whether the lines deemed
positive in our PCR screen correlated with expression of
the transgene in MuSCs. For this purpose, the five posi-
tive lines (#1, #3, #4, #5, #6) were expanded. MuSCs iso-
lated from adult skeletal muscles were further screened
for EGFP expression by flow cytometry (Table 1).
Transgenic mouse line #5, which displayed the most
robust EGFP signal by FACS analysis (Table 1 and
Additional file 5: Figure S4) was the founder used to
generate the Pax7EGFP colony. To determine the exact
number of the transgene integrations into the genome of
this line, we used a copy number variation assay. Our
analysis showed integration of the transgene into two
sites in a heterozygous mouse, and four sites in a homo-
zygous mouse (Additional file 2: Figure S2a). The num-
ber of integrations correlates well with the high integrity
and expression of EGFP observed in muscle stem cells
of the mouse line (Fig. 1a). However, we have found a
reduction in MuSC number in Pax7EGFP homozygotes
(Additional file 2: Figure S2b), presumably due to the
increased number of integrations that often increases
Table 1 Screening of transgenic mouse lines
Mouse line EGFP expression (FACS analysis)
Pax7EGFP-1 Negative
Pax7EGFP-3 Very low
Pax7EGFP-4 Negative
Pax7EGFP-5 HIGH
Pax7EGFP-6 Negative
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instability [39]. Thus, analyses of MuSCs were con-
ducted on heterozygous Pax7EGFP mice.
Isolation of GFP+ cells from Pax7EGFP muscles reveals
labeling of MuSCs with high fidelity
To test the strength of the fluorescence signal in our
Pax7EGFP MuSCs, we further characterized them by
FACS analysis and found robust expression (> 3 orders of
magnitude) of EGFP in the MuSC population (defined as
lineage−CD34+/α7-integrin+), while control (Pax7EGFP
negative) MuSCs expressed no GFP (Fig. 1a and
Additional file 5: Figure S4). To determine whether the
specificity of EGFP is confined to MuSCs, the proportion
of isolated MuSCs that expressed EGFP was determined
by flow cytometry. Our analysis demonstrates that > 80%
of MuSCs (CD34+/α7-integrin+) derived from Pax7EGFP
mice (1.5–3 months old) express EGFP (Fig. 1b and
Additional file 5: Figure S4). In addition, no EGFP expres-
sion was observed in the CD34−/ α7-integrin−/Sca1+/
CD11b+/CD31+/CD45+ populations in these mice
(Additional file 5: Figure S4). As an additional control, we
included Pax7Cre/RosamTmG mice, where GFP expression
depends on Pax7-driven Cre recombination. Similar to
what we observed with our Pax7EGFP mouse line, ~ 80%
of CD34+/α7-integrin+ cells expressedGFP (Additional file 3:
Figure S3). This consistency demonstrates the specificity of
a b
c
d
Fig. 1 EGFP expression in MuSCs of Pax7EGFP muscles. a Representative flow cytometry plots of MuSC populations (CD11b−/CD31−/CD45−/
Sca1−/CD34+/α7-integrin+) derived from control (Pax7EGFP negative) and Pax7EGFP mice (left). MuSCs were then analyzed for the presence of
GFP (right). b Assessment of the percent of MuSCs from (a) that are GFP+. c Analysis of GFP+ cells that are also CD34+ and α7-integrin+.
d Immunofluorescence staining of FACS-isolated MuSCs for Pax7 and GFP show all cells co-express both markers. Scale bar = 100 μm.
n > 3 mice per genotype
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our Pax7EGFP mouse in labeling MuSCs. Further
characterization of the Pax7EGFP MuSCs shows that all of
the EGFP+ cells (~ 100%) derived from the Pax7EGFP
mouse were also MuSCs (CD34+/α7-integrin+) (Fig. 1c),
demonstrating that the EGFP+ cells derived from the Pax7-
EGFP line are an ample source of MuSCs that are also
CD34+/α7-integrin+. We next assayed the number of
EGFP+ cells that are also Pax7+ in vitro and found that the
EGFP+ cells also co-stained for Pax7 (Fig. 1d), indicating a
high specificity of EGFP in labeling MuSCs. Altogether,
these data suggest that the Pax7EGFP mouse is a tool
for straightforward isolation of MuSCs, using the
EGFP signal.
Pax7EGFP- and wild-type-derived MuSCs have similar
myogenic properties
To further explore the myogenic performance of Pax7-
EGFP cells, we evaluated the expression levels of the
early myogenic marker, MyoD, and found no difference
between groups (Fig. 2a, b), suggesting similar myogenic
capabilities between Pax7EGFP and wild-type MuSCs.
EdU incorporation analysis and TUNEL staining also
confirmed the similarity in proliferation capacity and cell
death of these cells in vitro (Additional file 6: Figure
S5a–d). These results are consistent with a previous re-
port that showed constitutive expression of Pax7 in
satellite cell-derived myoblasts did not affect MyoD ex-
pression or proliferation [17]. To assess the effect of the
Pax7EGFP transgene on MuSC differentiation, the ex-
pression of two established later myogenic markers,
myogenin, and myosin heavy chain (MyHC), were quer-
ied (Fig. 2c). The percentage of positive cells for these
markers were not significantly different between cultures
derived from Pax7EGFP-mice compared with wild-type
cultures (Fig. 2d), indicating that there is no differenti-
ation impairment of Pax7EGFP cells. Together, the iden-
tical proliferation and differentiation properties between
Pax7EGFP and wild-type MuSCs confirms that the
transgene does not interfere with the typical myogenesis
process in vitro.
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Fig. 2 Myogenic potential of Pax7EGFP MuSCs in vitro. a MuSCs from either genotype were plated on laminin-coated chamber slides in growth
medium for 2 days, prior to fixation and staining for Pax7 and MyoD. Scale bar = 100 μm. b Quantitation of MyoD positively stained cells in (a).
n≥ 3 mice per genotype and N > 500 cells per condition analyzed. c MuSCs from control or Pax7EGFP mice were grown first in proliferation
medium for 5 days and then switched to differentiation medium for 2 days, fixed, and stained for the differentiation markers Myosin Heavy Chain
(MyHC) and myogenin. Scale bar = 100 μm. d Quantitation of data displayed above. n ≥ 3 mice analyzed per group with N > 1000 cells analyzed
per group
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Visualization by fluorescence microscopy reveals that
Pax7-driven EGFP is a dynamic marker of MuSC stemness
The myogenic program is orchestrated by the progression
from quiescence, activation, proliferation, and differenti-
ation (reviewed in [18, 40]). Quiescent MuSCs express the
transcription factor Pax7 [2]. Upon activation, MuSCs
proliferate, downregulate Pax7, and differentiate [17, 18].
To verify the precision of our Pax7-driven EGFP mice in
mirroring what occurs during a typical myogenesis
process, we monitored the levels of EGFP expression over
time (Fig. 3a). Interestingly, we found that the expression
of EGFP decreases shortly after plating (Fig. 3b), as ex-
pected in cells that are in transition from a quiescent state
towards a more activated/committed phase [17, 18]. The
temporal expression pattern of Pax7EGFP-derived MuSCs
recapitulates the reported Pax7 expression pattern of
MuSCs [2, 17, 18, 40–43] and demonstrates the feasibility
of using the EGFP signal in our transgenic mouse as a dy-
namic marker of MuSCs.
Robust and persistent Pax7EGFP expression in embryos
and adult tissues
To test whether the EGFP expression pattern in Pax7-
EGFP mice follows that of the endogenous Pax7 protein
during development, we analyzed whole embryos at two
representative embryonic days (e11.5 and e14.5). EGFP
expression was clearly observed in the somites, fronto-
nasal region, and neural tube in e11.5 dpc embryos,
while expression was found in the brain, frontonasal re-
gion, and skeletal muscles of the arms and legs in e14.5
dpc embryos (Fig. 4a). This analysis demonstrates that
the EGFP expression pattern in the Pax7EGFP mice rep-
licates the spatiotemporal expression that was previously
reported for Pax7 [10, 12, 43–45] and confirms that
Pax7EGFP is a functional equivalent reporter of Pax7.
To determine the specificity of Pax7 promoter-driven
GFP expression in adult skeletal muscles, the localization
of Pax7 and GFP was determined in cryosections by im-
munofluorescence microscopy. We consistently observed
b
a
Fig. 3 GFP expression in Pax7EGFP-derived MuSCs is dynamic. a FACS-sorted Pax7EGFP MuSCs were imaged daily for the presence of EGFP for
4 days. Scale bar = 100 μm. b Quantification of the signal intensities of Pax7EGFP MuSCs, with cell size taken into account, and normalized to the
percent fluorescence intensity observed after initial plating. MuSCs were individually analyzed from n = 3 Pax7EGFP heterozygous mice. Displayed
as median with interquartile range
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colocalization of Pax7 staining with GFP staining in adult
Pax7EGFP muscles (Fig. 4b, Additional file 7: Figure S6).
Importantly, in our mouse line the EGFP is evident under
fluorescence microscopy post-fixation, even without the
use of a GFP antibody (Fig. 4c). The usefulness of our
Pax7EGFP mouse is further demonstrated by in vivo im-
aging of MuSCs in whole muscles. Specifically, by using
two-photon microscopy, we found that EGFP is detectable
in the satellite cell position within the skeletal muscles of
Pax7EGFP mice (Fig. 4d). In summary, these data demon-
strate the specificity of EGFP expression driven by the
Pax7 promoter in our mouse line and highlights its bright
expression in the satellite cell position of live and fixed
adult skeletal muscles.
Typical skeletal muscle homeostasis and regeneration
abilities in Pax7EGFP mice
We previously showed that the insertion of the
Pax7-EGFP transgene in the genome does not affect the
myogenic progress in vitro (Fig. 2). To further evaluate if
such a possibility exists in vivo, the gastrocnemius,
quadriceps, and tibialis anterior muscles of Pax7EGFP
a
c
d
b
Fig. 4 GFP expression patterns in tissues of Pax7EGFP mice. a Whole embryos were isolated from timed matings of Pax7EGFP heterozygous mice
with wild-type mice and imaged for green fluorescence. Images were merged with brightfield images. Top: e11.5 dpc embryos. Note expression
of GFP in the nasal region and somites. Middle: imaging of e14.5 dpc embryos. Bottom: close-up image of e14.5 dpc embryos demonstrating
expression in the forelimb and hindlimb musculature. b Pax7 and GFP co-localize in vivo. Non-injured TA muscles were fixed and stained with
antibodies against Pax7 and GFP, and co-stained with both DAPI and fluorescently tagged-WGA (ECM). Scale bar = 50 μm. Note the clear overlap
in expression. Data were confirmed in n > 4 mice. c EGFP signal is present in TA tissue sections of Pax7EGFP mice without the need to stain with
GFP antibody. d Two photon imaging of the tibialis anterior (longitudinal) of live Pax7EGFP mice in vivo. Left: muscle fibers. Middle: Pax7EGFP
positive cells. Right: Merged image. Note the distinct GFP signal present in the satellite cell position. Scale bar = 200 μm
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heterozygous or control (Pax7EGFP negative) mice were
harvested and weighed, prior to histological staining.
Muscle weights were normalized to total body weight of
the harvested mouse to account for any potential
abnormalities resulting from mouse size/age. We found
no overt differences in the morphologies (Fig. 5a),
muscle weight (Fig. 5b), fiber area (Fig. 5c), or number
of fibers (Fig. 5d) in all examined skeletal muscles
a
e
b
d
c
f g
Fig. 5 Histological analysis of Pax7EGFP mice. a Representative images of gastrocnemius muscles from control (Pax7EGFP negative, top) or
Pax7EGFP heterozygous mice (Bottom) stained with hematoxylin and eosin. b Quantitation of the gastrocnemius muscle weight normalized to
body weight of each mouse. Further analyses included analysis of (c) fiber area of the gastrocnemius muscles between genotypes and (d)
number of muscle fibers per section. n ≥ 3 age and gender-matched mice per genotype per condition. e Representative images of control and
Pax7EGFP tibialis anterior muscles following injury. Tibialis anterior muscles were injured with notexin or left non-injured (left), and muscles were
harvested 5 (middle) or 10 (right) days post-injury. Muscles were cryosectioned and stained with hematoxylin and eosin and imaged. Scale bar = 100 μm. f
and g Quantitation of centrally nucleated fibers. n≥ 3 mice per genotype per condition. N > 500 fibers analyzed per genotype per condition
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between control and Pax7EGFP+ mice (Additional file 8:
Figure S7). To evaluate the behavior of Pax7EGFP mice
under regeneration conditions, we induced muscle injury
with notexin. Histological examination of cross-sections
(Fig. 5e) revealed no apparent defects in regeneration ei-
ther 5 or 10 days after injury (Fig. 5f, g). In aggregate,
these data demonstrate that Pax7EGFP mice appear
morphologically similar to controls, both in homeostatic
and injury conditions, which argues against a positional
effect arising from the transgene insertion. Finally, to
confirm that Pax7EGFP-labeled cells function as MuSCs
during regeneration, we stained tibialis anterior cryosec-
tions from non-injured or notexin-injured Pax7EGFP
heterozygous mice with Pax7 and GFP antibodies and
analyzed the level of overlap between Pax7+ cells and
GFP+ cells (Additional file 9: Figure S8a). We found
substantial overlap between these cell populations
(Additional file 9: Figure S8b) in the early stages (D5)
and later stages (D10) of regeneration. These data reveal
that GFP+ cells from the Pax7EGFP mouse label MuSCs
and function in a typical manner during the regeneration
process.
Discussion
Pax7 is the most utilized marker of quiescent satellite
cells [18]. Pax7 labels all stem cells in the adult muscle
with myogenic potential [46]. Although previously gen-
erated Pax7 reporter lines [19, 44] have yielded import-
ant insights of muscle stem cells using prospective cell
isolation methods, they failed to mark Pax7+ cells in vivo
(native and live) in adult mice. Here, we showed the
successful generation and detailed characterization of a
new transgenic mouse with a bright EGFP fluorescence,
which is optimal for labeling Pax7+ cells in vivo. The
overall stronger in vivo expression of our Pax7EGFP line
compared to the Pax7zsGreen line could be explained
by the differences between a monomeric GFP and a
cytoplasmic tetrameric protein [47, 48], the different
BAC clones used to generate the targeting vector and/or
differences of the integration site. Similarly, the different
BAC clone used to generate the Pax7-nGFP line [19, 49]
is likely to impact the levels of EGFP live expression. A
common obstacle in generating transgenic mice from
BAC chromosomes has been the poor expression of the
transgene due to positional effects [50]. The high expres-
sion of EGFP in the Pax7EGFP line argues against inte-
gration into a heterochromatin region of the genome.
Due to the technical inability to locate the defined gen-
omic locus of the BAC insertions [50], we determined
the number of insertions and further analyzed the myo-
genic properties of Pax7EGFP muscles. The normal
in vitro myogenic potential together with the ordinary
muscle morphology and in vivo regeneration potential
exclude the possibility that the BAC integration is affect-
ing a muscle-relevant gene.
To fully characterize the properties of Pax7EGFP cells,
we have isolated MuSCs using α7-integrin and CD34 cell
surface markers and we have identified that > 80% of
MuSCs were also positive for GFP expression. These
data are in line with research that displayed similar per-
centages, when Pax7-positive cells were assayed for dif-
ferent typical cell surface markers used in the isolation
of MuSCs, including CXCR4/β1-integrin, VCAM, and
α7-integrin/CD34 [22]. Importantly, we found that all
EGFP+ cells in the Pax7EGFP muscles are also Pax7+, as
expected if all necessary sequences in the promoter re-
gion that required to establish the native Pax7 genetic
organization are present. While flow cytometry is a very
sensitive tool, fluorescence signals detectable by FACS
are not always strong enough to be identified by micros-
copy at the same time [51], limiting the usefulness of a
reporter line. To assess the intensity of EGFP in our
Pax7EGFP mice, we plated and imaged isolated MuSCs
by fluorescence microscopy. We found that the EGFP
expression was very bright in all isolated cells, dem-
onstrating that the levels of GFP expression are high
and detectable by both flow cytometry and fluores-
cence microscopy.
Despite a recent debate regarding the exact role of Pax7
in adult muscles [32–34], the ability of Pax7 expressing
stem cells to contribute to skeletal muscle regeneration is
indisputable. However, the Pax7 mechanisms that pre-
serve stem cell homeostasis in uninjured tissues, its role
as a chromatin modifier and its requirements in resident
non-muscle cells remain to be elucidated (discussed in
[35]). Our analysis revealed that the EGFP in the Pax7-
EGFP line is dynamic, recapitulating the temporal
endogenous Pax7 expression pattern. Although the Pax7-
EGFP mouse cannot be used to follow cells that then lose
their stemness and downregulate Pax7 (therefore become
EGFP negative), it could be extremely useful to follow the
molecular physiology of Pax7 in in vivo self-renewal, het-
erogeneity, and asymmetric cell division of MuSCs. In
addition, a recent study reported an unexpected role of
Pax7 in maintenance of the heterochromatin state [32]. It
would be interesting to analyze in detail these properties
using the Pax7EGFP line in conjunction with histone
markers. Furthermore, it has been reported that muscle
resident non-satellite cells, such as PW1+ cells [52, 53] or
pericytes [54], transiently activate the Pax7 promoter and
participate in muscle repair. Our Pax7EGFP line in com-
bination with specific markers for these populations will
be useful in following these transient populations as they
contribute to muscle repair. Finally, MuSC dysregulation
is a physiologically relevant topic, particularly in degenera-
tive muscle diseases, where stem cell defects lead the
disease progression [55–57].
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Overall, we show that our mouse line drives EGFP ex-
pression in a cell-specific manner that is easily detectable
and has informative physiological effects. We propose that
this mouse model will be beneficial for anyone studying
muscle stem cell motility and/or regeneration in an
in vivo setting. Given the intense fluorescent signal,
this mouse could be used to visualize MuSCs in a
steady state to understand their cell-autonomous
function, as well as how they migrate and behave
following injury.
Conclusion
Here, we have described the creation and characterization
of a new mouse model, where EGFP fluorescence is driven
by Pax7 expression. We found EGFP expression to be
robust and dynamic, and the EGFP labeled cells can be
easily isolated by flow cytometry and/or followed using
live imaging in vivo. We conclude that EGFP is a reliable
tool for convenient monitoring of Pax7+ cells, and we
propose that this mouse line can be of great benefit to the
satellite cell/MuSC field to understand the role of Pax7 in
stem cell homeostasis, heterogeneity, and asymmetric cell
division in healthy and/or disease conditions.
Additional files
Additional file 1: Figure S1. Generation of the Pax7EGFP mouse. (a)
Schematic of the Pax7-EGFP targeting BAC that was used to generate the
Pax7EGFP line. (b) Agarose gel depicting PCR-genotyped mouse lines
from Table 1. A mouse carrying the Pax7EGFP transgene yields a single
product of 706 bp. Control (wild-type) mice produce no band at this size.
(PDF 442 kb)
Additional file 2: Figure S2. Pax7EGFP copy number variation analysis
and in-depth genotyping, and effect of transgene integrations on MuSCs.
(a) Genomic DNA was isolated and purified from three Rosamtmg /Pax7Cre
heterozygous mice (containing 1 GFP genomic copy), as well as from
two mice each of wild-type, Pax7EGFP heterozygous, and Pax7EGFP
homozygous backgrounds (one from each gender). Purified DNA was
subjected to a TaqMan Copy Number Variation Assay, according to the
manufacturer’s instructions. Data were normalized to the one copy number
present in the RosamT/mG /Pax7 Cre heterozygous mice. (b) MuSCs were
isolated from Pax7EGFP heterozygous or homozygous mice by FACS. Note
the reduction of MuSC numbers in homozygotes. (PDF 123 kb)
Additional file 3: Figure S3. MuSCs from Pax7EGFP mice are similar to
Pax7-labeled MuSCs. (a) MuSCs were isolated as in Fig. 1 from Pax7EGFP
heterozygous mice and RosamTmG/Pax7Cre dual heterozygous mice. (b)
Evaluation of the percent of MuSCs in (a) that are also EGFP+. (PDF 316 kb)
Additional file 4: Supplementary methods [56, 58]. (DOCX 23 kb)
Additional file 5: Figure S4. FACS schematic of MuSC isolation. Top:
gating strategy for the gate selection of parent populations of muscle
cell isolates, singlets, and live cells (7-AAD negative). Measurement of
GFP+ cells in lineage positive cell populations (Sca1+/CD11b+/CD31+/
CD45+) showed no GFP expression (red). Bottom: MuSC enrichment by
gating CD11b−/CD45−/CD31−/Sca1− (lineage negative) populations
followed by gating for CD34+/α7-integrin+ and finally the populations of
GFP+ cells from Pax7EGFP mice (green) or control mice (cyan) was
displayed as histograms. (PDF 3145 kb)
Additional file 6: Figure S5. Analysis of MuSC proliferation and cell death.
(a) Measurement of proliferative capacity in MuSCs derived from control or
Pax7EGFP mice. FACS-sorted MuSCs were plated on laminin-coated chamber
slides in myoblast media containing bFGF for 2 days. EdU was added to the
culture media, and cells were incubated for 2 h. Cells were fixed, and EdU
incorporation was assayed by fluorescence microscopy. As a control, some
cells were not treated with EdU. Scale bar = 100 μm. (b) Quantitation of data
shown in (a). n≥ 3 mice assayed, with at least N= 700 cells analyzed per
group. (c) Measurement of cell death levels in FACS-sorted MuSCs by TUNEL
assay. Cells were plated as in (a) and processed as described in the methods.
As a positive control, fixed cells were treated with DNase. Scale bar = 100 μm
(d) Quantitation of cell death levels shown in (c). ND, none detected. n≥ 3
mice were analyzed; N> 400 cells were analyzed. (PDF 3145 kb)
Additional file 7: Figure S6. Technical immunofluorescence control for
Fig. 4b. (Left) Pax7EGFP negative mouse TA muscle cryosections were
stained with Pax7 and GFP antibodies. (Right) TA muscle cryosections of
Pax7EGFP mice processed the same as control muscle tissue, with the
exception of no Pax7 or GFP antibody staining occurred. Note: while the
GFP signal of Pax7EGFP mice survives our fixation protocol for
cryosectioning, it does not survive EDTA-mediated antigen retrieval
necessary for Pax7 staining. (PDF 89 kb)
Additional file 8: Figure S7. Histological analysis of additional Pax7EGFP
muscles. Representative images of quadriceps (a) and tibialis anterior (b)
muscles from non-injured control (top) or Pax7EGFP heterozygous mice
(bottom) stained with hematoxylin and eosin. (c–d) Individual muscle
weights were normalized to total body weight per mouse. (e–f) Analysis of
muscle fiber number. (g–h) Quantification of muscle fiber area. n = at least 3
mice (age and gender-matched) per genotype per condition. (PDF 180 kb)
Additional file 9: Figure S8. Overlap of Pax7+ and GFP+ cells during
regeneration. (a) Imaging of tibialis anterior cryosections stained with
Pax7 and GFP under conditions of no injury, or 5 and 10 days post-injury.
(b) Quantification of Pax7+ cells that overlap with GFP+ cells. n = 2–3 mice
per condition. Displayed is the mean ± standard deviation. (PDF 605 kb)
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